You are here

  • Home
  • Archive
  • Volume 9, Issue 7
  • Co-delivery of novel bispecific and trispecific engagers by an amplicon vector augments the therapeutic effect of an HSV-based oncolytic virotherapy

Article metrics

Article menu
Oncolytic and local immunotherapy
Original research
Co-delivery of novel bispecific and trispecific engagers by an amplicon vector augments the therapeutic effect of an HSV-based oncolytic virotherapy

 

Online download statistics by month:

Online download statistics by month: July 2021 to October 2024

AbstractFullPdf
Jul 2021354354159
Aug 202113613646
Sep 202112412469
Oct 202113613644
Nov 2021999940
Dec 2021747416
Jan 2022758233
Feb 2022474922
Mar 2022747844
Apr 2022697541
May 2022565633
Jun 2022565723
Jul 2022364412
Aug 2022515529
Sep 2022414120
Oct 2022575930
Nov 2022515116
Dec 2022333317
Jan 2023363624
Feb 2023777625
Mar 2023282836
Apr 2023252637
May 2023333316
Jun 2023333317
Jul 2023242418
Aug 2023101013
Sep 2023303010
Oct 2023232412
Nov 2023333318
Dec 202320208
Jan 2024363814
Feb 2024292914
Mar 2024474766
Apr 2024464747
May 2024444530
Jun 2024323119
Jul 2024475025
Aug 2024313319
Sep 2024353511
Oct 2024353617
Total232323671190